Koumaki D, Papadakis M, Kouloumvakou S, Krasagakis K. Awareness, knowledge, and attitudes towards sun protection among patients with melanoma and atypical mole syndrome. World J Clin Oncol 2022; 13(7): 587-598 [PMID: 36157160 DOI: 10.5306/wjco.v13.i7.587]
Corresponding Author of This Article
Marios Papadakis, MD, MSc, PhD, Consultant Physician-Scientist, Doctor, Research Scientist, Department of Surgery II, University of Witten-Herdecke, Heusnerstrasse 40, Wuppertal 42283, Germany. marios_papadakis@yahoo.gr
Research Domain of This Article
Dermatology
Article-Type of This Article
Case Control Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Oncol. Jul 24, 2022; 13(7): 587-598 Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.587
Table 1 Demographic and clinical characteristics of 121 patients who were included in our study
Patients with a PMH of MM, n = 26/121 (21.5%)
Patients with AMS, n = 47/121 (38.8%)
Control group, n = 48/121 (39.7%)
All participants, n = 121
P value
Mean age (± SD)
45.65 (± 12.61)
43.21 (± 12.61)
43.67 (± 12.65)
43.92 (± 12.55)
0.88
Gender, n (%)
0.39
Male
10/26 (38.5)
25/47 (53.2)
20/48 (41.7)
55/121 (45.5)
Female
16/26 (61.5)
22/47 (46.8)
28/48 (58.3)
66/121 (54.5)
Employment Status, n (%)
0.40
Student
2/26 (7.7)
3/47 (6.4)
2/48 (4.2)
7/121 (5.8)
Employed
16/26 (61.5)
36/47 (76.6)
33/48 (68.8)
85/121 (70.2)
Unemployed
2/26 (7.7)
4/47 (8.5)
7/48 (14.6)
13/121 (10.7)
Retired
5/26 (19.2)
3/47 (6.4)
3/48 (6.3)
11/121 (9.1)
Housewife
1/26 (3.8)
1/47 (2.1)
3/48 (6.3)
5/121 (4.1)
Educational level, n (%)
0.61
Elementary school
9/26 (34.6)
1/47 (2.1)
3/48 (6.3)
4/121 (3.3)
High school
0/26 (0)
20/47 (42.6)
21/48 (43.8)
50/121 (41.3)
Technical studies
6/26 (23.1)
8/47 (17)
5/48 (10.4)
19/121 (15.7)
University level
11/26 (42.3)
18/47 (38.3)
19/48 (39.6)
48/121 (39.7)
Fitzpatrick skin phototype, n (%)
0.81
Skin type I (Always burns, does not tan)
0/26 (0)
2/47 (4.3)
2/48 (4.2)
4/121 (3.3)
Skin type II (Burns easily, tans poorly)
10/26 (38.5)
14/47 (29.8)
15/48 (31.3)
39/121 (32.2)
Skin type III (Tans after initial burn)
14/26 (53.8)
24/47 (51.1)
22/48 (45.8)
60/121 (49.6)
Skin type IV (Burns minimally, tans easily)
2/26 (7.7)
7/47 (14.9)
9/48 (18.8)
18/121 (14.9)
BMI (± SD)
25.07 (± 4.06)
26.92 (± 5.12)
25.58 (± 5.20)
25.99 (± 4.96)
0.281
Eye colour, n (%)
0.466
Dark
1/26 (3.8)
2/47 (4.3)
5/48 (10.4)
8/121 (6.6)
Brown
16/26 (61.5)
31/47 (66)
31/48 (64.4)
78/121 (64.5)
Blue
3/26 (11.5)
9/47 (19.1)
5/48 (10.4)
17/121 (14)
Green
6/26 (23.1)
5/47 (10.6)
7/48 (14.6)
18/121 (18)
Natural hair color, n (%)
0.649
Red
0/26 (0)
1/47 (2.1)
0/48 (0)
1/121 (0.8)
Blond
5/26 (19.2)
6/47 (12.8)
8/48 (16.7)
19/121 (15.7)
Brown
16/26 (61.5)
34/47 (72.3)
28/48 (58.3)
78/121 (64.5)
Black
5/26 (19.2)
6/47 (12.8)
12/48 (25)
23/121 (19)
Number of naevi, n (%)
0.000
< 25 naevi
9/26 (34.6)
0/47 (0)
23/48 (47.9)
32/121 (26.4)
25-50 naevi
8/26 (30.8)
2/47 (4.3)
12/48 (25)
22/121 (18.2)
50-100 naevi
3/26 (11.5)
11/47 (23.4)
7/48 (14.6)
21/121 (17.4)
100 naevi
6/26 (23.1)
34/47 (72.3)
6/48 (12.5)
46/121 (38)
Smoking status, n (%)
Current smoker
8/26 (30.8)
15/47 (31.9)
9/48 (18.8)
32/121 (26.4)
0.198
No smoker
15/26 (57.7)
25/47 (53.2)
28/48 (58.3)
68/121 (56.2)
Ex-smoker
3/26 (11.5)
7/47 (14.9)
11/48 (22.9)
21/121 (17.4)
Sunburn before the age of 18, n (%)
0.000
No
9/26 (34.6)
30/47 (63.8)
40/48 (83.3)
79/121 (65.3)
Yes
17/26 (65.4)
17/47 (36.2)
8/48 (16.7)
42/121 (34.7)
Leisure sun exposure, n (%)
0.393
No
17/26 (65.4)
31/47 (66)
38/48 (79.2)
86/121 (71.1)
Yes
9/26 (34.6)
16/47 (34)
10/48 (20.8)
35/121 (28.9)
Occupational sun exposure, n (%)
0.35
No
19/26 (73.1)
27/47 (57.4)
30/48 (62.5)
76/121 (62.8)
Yes
7/26 (26.9)
20/47 (42.6)
18/48 (37.5)
45/121 (37.2)
Significant time spent outdoors, n (%)
0.356
No
11/26 (42.3)
24/47 (51.1)
28/48 (58.3)
63/121 (52.1)
Yes
15/26 (57.7)
23/47 (48.9)
20/48 (42.7)
58/121 (47.9)
Mean weeks of vacation spent before the age of 10 (± SD)
7.35 ± 5.61
6.87 ± 5
7.42 ± 4.36
7.19 ± 4.86
0.7444
Mean weeks of vacation spent before from the age of 11 till 18 (± SD)
6.12 ± 4.27
6.38 ± 4.44
6.94 ± 4.20
6.55 ± 4.29
0.740
Mean weeks of vacation spent after the age of 18 (± SD)
3.92 ± 2.1
4.02 ± 2.77
4.98 ± 4.35
4.39 ± 3.40
0.806
Table 2 Sun protection practices in patients with malignant melanoma, those with atypical mole syndrome, and controls
Patients with a PMH of MM, n = 26
Patients with AMS, n = 47
Control group, n = 48
All participants, n = 121
P value
Do you use sunscreen? n (%)
No
5/26 (19.2)
7/47 (14.9)
5/48 (10.4)
17/121(14)
0.461
Yes
21/26 (80 .8)
40/47 (85.1)
43/48 (89.8)
104/121 (86)
If yes, which SPF sunblock rating do you use? n (%)
< 30
2/26 (7.7)
5/47 (10.6)
9/48 (18.8)
16/121 (13.2)
0.222
≥ 30
7/26 (26.9)
10/47 (21.3)
14/48 (29.2)
31/121 (25.6)
≥ 50
12/26 (46.2)
25/47 (53.2)
20/48 (41.7)
57/121 (47.1)
No sunscreen use
5/26 (19.2)
7/47 (14.9)
5/48 (10.4)
17/121 (14)
How frequently do you use sunscreen? n (%)
Everyday
5/26 (19.2)
6/47 (12.8)
11/48 (22.9)
22/121 (18.2)
0.663
Most days
4/26 (15.4)
13/47 (27.7)
10/48 (20.8)
27/121 (22.3)
Occasionally
11/26 (42.3)
18/47 (38.3)
18/48 (37.5)
47/121 (38.8)
Rarely
1/26 (3.8)
3/47 (6.4)
4/48 (8.3)
8/121 (6.6)
No sunscreen use
5/26 (19.2)
7/47 (14.9)
5/48 (10.4)
17/121 (14)
During which seasons do you apply sunscreen? n (%)
Only during the summer
17/26 (65.4)
37/47 (78.7)
30/48 (62.5)
84/121 (69.4)
0.353
All year-round
4/26 (15.4)
3/47 (6.4)
13/48 (27.1)
20/121 (16.5)
No sunscreen use
5/26 (19.2)
7/47 (14.9)
5/48 (10.4)
17/121 (14)
In which of the following weather conditions do you apply sunscreen? n (%)
Only in direct sunny weather
17/26 (65.4)
38/47 (80.9)
34/48 (70.8)
89/121 (73.6)
0.606
Both sunny and cloudy weather
4/26 (15.4)
2/47 (4.3)
9/48 (18.8)
15/121 (12.4)
No sunscreen use
5/26 (19.2)
7/47 (14.9)
5/48 (10.4)
17/121 (14)
While outdoors, do you reapply sunscreen? n (%)
No
16/26 (61.5)
21/47 (44.7)
33/48 (68.8)
70/121 (57.9)
0.31
Yes
10/26 (38.5)
26/47 (55.3)
15/48 (31.3)
51/121 (42.1)
Do you reapply sunscreen after swimming or perspiring heavily? n (%)
No
14/26 (53.8)
20/47 (42.6)
28/48 (58.3)
62/121 (51.2)
0.139
Yes
12/26 (46.2)
27/47 (57.4)
20/48 (41.7)
59/121 (48.8 )
Wearing UV-protective sunglasses, n (%)
Everyday
13/26 (50)
21/47 (44.7)
12/48 (25)
46/121 (38)
0.303
Most days
5/26 (19.2)
10/47 (21.3)
16/48 (33.3)
31/121 (25.6)
Occasionally
2/26 (7.7)
7/47 (14.9)
13/48 (27.1)
22/121 (18.2)
Rarely
1/26 (3.8)
4/47 (8.5)
4/48 (8.3)
9/121 (7.4)
Never
5/26 (19.2)
5/47 (10.6)
3/48 (6.3)
13/121 (10.7)
Wearing a broad-brimmed hat, n (%)
Everyday
5/26 (19.2)
3/47 (6.4)
3/48 (6.3)
11/121 (9.1)
0.535
Most days
1/26 (3.8)
6/47 (12.8)
6/48 (12.5)
13/121 (10.7)
Occasionally
6/26 (23.1)
14/47 (29.8)
13/48 (27.1)
33/121 (27.3)
Rarely
7/26 (26.9)
13/47 (27.7)
6/48 (12.5)
26/121 (21.5)
Never
7/26 (26.9)
11/47 (23.4)
20/48 (41.7)
38/121 (31.4)
Wearing long-sleeved shirts or long plants made from tight fabric weave, n (%)
Everyday
1/26 (3.8)
2/47 (4.3)
1/48 (2.1)
4/121 (3.3)
0.275
Most days
4/26 (15.4)
11/47 (23.4)
9/48 (18.8)
24/121 (19.8)
Occasionally
7/26 (26.9)
13/47 (27.7)
16/48 (33.3)
36/121 (29.8)
Rarely
5/26 (19.2)
11/47 (23.4)
12/48 (25)
28/121 (23.1)
Never
9/26 (34.6)
10/47 (21.3)
10/48 (20.8)
29/121 (24)
Avoiding the sun during hours of peak sunlight intensity (10:00 am to 16:00 pm), n (%)
Everyday
8/26 (30.8)
9/47 (19.1)
5/48 (10.4)
22/121 (18.2)
0.492
Most days
10/26 (38.5)
20/47 (42.6)
26/48 (54.2)
56/121 (46.3)
Occasionally
4/26 (15.4)
11/47 (23.4)
13/48 (27.1)
28/121 (23.1)
Rarely
4/26 (15.4)
5/47 (10.6)
0/48 (0)
9/121 (7.4)
Never
0/26 (0)
2/47 (4.3)
4/48 (8.3)
6/121 (5)
Table 3 Sun protection education in patients with malignant melanoma, those with atypical mole syndrome, and controls
Patients with a PMH of MM, n = 26
Patients with AMS, n = 47
Control group, n = 48
All participants, n = 121
P value
Have you ever been given advice on how to protect your skin from sunlight? n (%)
No
6/26 (23.1)
9/47 (19.1)
16/48 (33.3)
31/121 (25.6)
0.59
Yes
20/26 (76.9)
38/47 (80.9)
32/48 (66.7)
90/121 (74.4)
Have you ever received sun protection education from a family doctor? n (%)
No
6/26 (23.1)
11/47 (23.4)
18/48 (37.5)
35/121 (28.9)
0.109
Yes
20/26 (76.9)
36/47 (76.6)
30/48 (62.5)
86/121 (71.1)
On how many occasions have you received sun protection education from a healthcare professional? n (%)
Never
5/26 (19.2)
10/47 (21.3)
14/48 (29.2)
29/121 (24)
0.316
Once
4/26 (15.4)
5/47 (10.6)
6/48 (12.5)
15/121 (12.5)
Twice
3/26 (11.5)
6/47 (12.8)
8/48 (16.7)
17/121 (14)
3 times
4/26 (15.4)
5/47 (10.6)
6/48 (12.5)
15/121 (12.5)
3 times
10/26 (38.5)
21/47 (44.7)
14/48 (29.2)
45/121 (37)
Have you ever received sun protection education from Media (i.e., television, newspaper)? n (%)
No
11/26 (42.3)
22/47 (46.8)
25/48 (52.1)
58/121 (47.9)
0.546
Yes
15/26 (57.57)
25/47 (53.2)
23/48 (47.9)
63/121 (52.1)
Have you ever received written advice about sun protection? n (%)
No
21/26 (80.8)
38/47 (80.9)
45/48 (93.8)
17/121 (14)
0.055
Yes
5/26 (19.2)
9/47 (19.1)
3/48 (6.3)
104/121 (86)
Would you be interested in receiving education about sun protection? n (%)
No
4/26 (15.4)
12/47 (25.5)
17/48 (35.4)
33/121 (27)
0.619
Yes
22/26 (84.6)
35/47 (74.5)
31/48 (64.6)
88/121 (73)
Would you be interested in receiving photoprotection advice about sun protection from a healthcare worker? n (%)
No
4/26 (15.4)
16/47 (34)
17/48 (35.4)
33/121 (27.3)
0.154
Yes
22/26 (84.6)
31/47 (66)
31/48 (64.6)
88/121 (72.7)
Would you be interested in receiving photoprotection advice about sun protection from multimedia? n (%)
No
11/26 (42.3)
16/41 (34)
20/48 (41.7)
47/121 (36.8)
0.693
Yes
15/26 (57.7)
31/41 (66)
28/48 (58.3)
74/121 (61.2)
Table 4 Perceived barriers to implementation of photoprotection practices in patients with malignant melanoma, those with atypical mole syndrome, and controls
Patients with a PMH of MM, n = 26
Patients with AMS, n = 47
Control group, n = 48
All participants, n = 121
P value
Have any of the following barriers discouraged you from practicing sun protection? n (%)
No
7/26 (26.9%)
27/47 (57.4%)
24/48 (50%)
58/121 (47.9%)
0.656
Yes
19/26 (73.1%)
20/47 (42.6%)
24/48 (50%)
63/121 (52.1%)
Skepticism (“I do not believe skin cancer is a serious health threat”), n (%)
No
22/26 (84.6%)
43/47 (91.5%)
45/48 (93.8%)
110/121 (90.9%)
0568
Yes
4/26 (15.4%)
4/47 (8.5%)
3/48 (6.3%)
11/121 (9.1%)
Hassle/lack of time, n (%)
No
21/26 (80.8%)
35/47 (74.5%)
38/48 (79.2%)
94/121 (77.7%)
0.639
Yes
5/26 (19.2%)
12/47 (25.5%)
10/48 (20.8%)
27/121 (22.3%)
Concerns over adequate Vitamin D, n (%)
No
20/26 (76.9%)
34/47 (72.3%)
32/48 (66.7%)
86/121 (71.1%)
0.486
Yes
6/26 (23.1%)
13/47 (27.7%)
16/48 (33.3%)
35/121 (28.9%)
Cost/financial concerns. n (%)
No
25/26 (96.2%)
38/47 (80.9%)
39/48 (81.3%)
102/121 (84.3%)
0.810
Yes
1/26 (3.8%)
9/47 (19.1%)
9/48 (18.8%)
19/121 (15.7%)
Appearance (“I do not like how using sun protection will make me look”), n (%)
No
24/26 (92.3%)
44/47 (93.6%)
48/48 (100%)
116/121 (95.9%)
0.090
Yes
2/26 (7.7%)
3/47 (6.4%)
0/48 (0%)
5/121 (4.1%)
Difficulty obtaining materials (sunscreen, sunglasses, hats, etc), n (%)
No
25/26 (96.2%)
44/47 (93.6%)
114/121 (94.2%)
0.962
Yes
1/26 (3.8%)
3/47 (6.4%)
7/121 (5.8%)
Sunscreen is uncomfortable or unpleasant, n (%)
No
22/26 (84.6%)
43/48 (91.5%)
47/48 (97.9%)
112/121 (93%)
0.149
Yes
4/26 (15.4%)
4/48 (8.5%)
1/48 (2.1%)
9/121 (7%)
Previous “bad” reaction to sunscreen (please specify), n (%)
No
25/26 (96.2%)
47/47 (100%)
48/48 (100%)
120/121 (99.2%)
0.765
Yes
1/26 (3.8%)
0/47 (0%)
0/48 (0%)
1/121 (0.8%)
None/no barriers have discouraged me, n (%)
No
14/26 (53.8%)
21/121 (44.7%)
23/48 (47.9%)
58/121 (47.9%)
0.840
Yes
12/26 (46.2%)
26/121 (55.3%)
25/48 (52.1%
63/121 (52.1%)
Citation: Koumaki D, Papadakis M, Kouloumvakou S, Krasagakis K. Awareness, knowledge, and attitudes towards sun protection among patients with melanoma and atypical mole syndrome. World J Clin Oncol 2022; 13(7): 587-598